Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $192,883 - $234,204
-15,954 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $3.85 Million - $4.39 Million
-290,293 Reduced 94.79%
15,954 $216,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $2.76 Million - $3.44 Million
-213,135 Reduced 41.04%
306,247 $4.38 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $289,032 - $394,308
21,268 Added 4.27%
519,382 $7.26 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $7.12 Million - $9.33 Million
498,114 New
498,114 $9.34 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.7B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.